Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Environmental suitability for lymphatic filariasis in Nigeria.

Eneanya OA, Cano J, Dorigatti I, Anagbogu I, Okoronkwo C, Garske T, Donnelly CA.

Parasit Vectors. 2018 Sep 17;11(1):513. doi: 10.1186/s13071-018-3097-9.

2.

Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning.

Dorigatti I, Donnelly CA, Laydon DJ, Small R, Jackson N, Coudeville L, Ferguson NM.

Nat Commun. 2018 Sep 7;9(1):3644. doi: 10.1038/s41467-018-06006-6.

3.

Using Wolbachia for Dengue Control: Insights from Modelling.

Dorigatti I, McCormack C, Nedjati-Gilani G, Ferguson NM.

Trends Parasitol. 2018 Feb;34(2):102-113. doi: 10.1016/j.pt.2017.11.002. Epub 2017 Nov 25. Review.

4.

International risk of yellow fever spread from the ongoing outbreak in Brazil, December 2016 to May 2017.

Dorigatti I, Hamlet A, Aguas R, Cattarino L, Cori A, Donnelly CA, Garske T, Imai N, Ferguson NM.

Euro Surveill. 2017 Jul 13;22(28). pii: 30572. doi: 10.2807/1560-7917.ES.2017.22.28.30572.

5.

Key data for outbreak evaluation: building on the Ebola experience.

Cori A, Donnelly CA, Dorigatti I, Ferguson NM, Fraser C, Garske T, Jombart T, Nedjati-Gilani G, Nouvellet P, Riley S, Van Kerkhove MD, Mills HL, Blake IM.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160371. doi: 10.1098/rstb.2016.0371. Review.

6.

Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016.

Garske T, Cori A, Ariyarajah A, Blake IM, Dorigatti I, Eckmanns T, Fraser C, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Van Kerkhove MD, Dye C, Ferguson NM, Donnelly CA.

Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721). pii: 20160308. doi: 10.1098/rstb.2016.0308.

7.

A simple approach to measure transmissibility and forecast incidence.

Nouvellet P, Cori A, Garske T, Blake IM, Dorigatti I, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Van Kerkhove MD, Fraser C, Donnelly CA, Ferguson NM, Riley S.

Epidemics. 2018 Mar;22:29-35. doi: 10.1016/j.epidem.2017.02.012. Epub 2017 Feb 24.

8.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N.

PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.

9.

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study.

International Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Bawo L, Bilivogui P, Blake IM, Brennan RJ, Cawthorne A, Cleary E, Clement P, Conteh R, Cori A, Dafae F, Dahl B, Dangou JM, Diallo B, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Fallah M, Ferguson NM, Fiebig L, Fraser C, Garske T, Gonzalez L, Hamblion E, Hamid N, Hersey S, Hinsley W, Jambei A, Jombart T, Kargbo D, Keita S, Kinzer M, George FK, Godefroy B, Gutierrez G, Kannangarage N, Mills HL, Moller T, Meijers S, Mohamed Y, Morgan O, Nedjati-Gilani G, Newton E, Nouvellet P, Nyenswah T, Perea W, Perkins D, Riley S, Rodier G, Rondy M, Sagrado M, Savulescu C, Schafer IJ, Schumacher D, Seyler T, Shah A, Van Kerkhove MD, Wesseh CS, Yoti Z.

PLoS Med. 2016 Nov 15;13(11):e1002170. doi: 10.1371/journal.pmed.1002170. eCollection 2016 Nov.

10.

Modelling the impact of co-circulating low pathogenic avian influenza viruses on epidemics of highly pathogenic avian influenza in poultry.

Nickbakhsh S, Hall MD, Dorigatti I, Lycett SJ, Mulatti P, Monne I, Fusaro A, Woolhouse MEJ, Rambaut A, Kao RR.

Epidemics. 2016 Dec;17:27-34. doi: 10.1016/j.epidem.2016.10.005. Epub 2016 Oct 19.

11.

Estimating transmission probability in schools for the 2009 H1N1 influenza pandemic in Italy.

Clamer V, Dorigatti I, Fumanelli L, Rizzo C, Pugliese A.

Theor Biol Med Model. 2016 Oct 12;13(1):19.

12.

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Ferguson NM, Rodríguez-Barraquer I, Dorigatti I, Mier-Y-Teran-Romero L, Laydon DJ, Cummings DA.

Science. 2016 Sep 2;353(6303):1033-1036.

13.

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

WHO Ebola Response Team, Agua-Agum J, Allegranzi B, Ariyarajah A, Aylward R, Blake IM, Barboza P, Bausch D, Brennan RJ, Clement P, Coffey P, Cori A, Donnelly CA, Dorigatti I, Drury P, Durski K, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garcia E, Garske T, Gasasira A, Gurry C, Hamblion E, Hinsley W, Holden R, Holmes D, Hugonnet S, Jaramillo Gutierrez G, Jombart T, Kelley E, Santhana R, Mahmoud N, Mills HL, Mohamed Y, Musa E, Naidoo D, Nedjati-Gilani G, Newton E, Norton I, Nouvellet P, Perkins D, Perkins M, Riley S, Schumacher D, Shah A, Tang M, Varsaneux O, Van Kerkhove MD.

N Engl J Med. 2016 Aug 11;375(6):587-96. doi: 10.1056/NEJMsr1513109. No abstract available.

14.

EPIDEMIOLOGY. Countering the Zika epidemic in Latin America.

Ferguson NM, Cucunubá ZM, Dorigatti I, Nedjati-Gilani GL, Donnelly CA, Basáñez MG, Nouvellet P, Lessler J.

Science. 2016 Jul 22;353(6297):353-4. doi: 10.1126/science.aag0219. Epub 2016 Jul 14. No abstract available.

15.

Estimating Dengue Transmission Intensity from Case-Notification Data from Multiple Countries.

Imai N, Dorigatti I, Cauchemez S, Ferguson NM.

PLoS Negl Trop Dis. 2016 Jul 11;10(7):e0004833. doi: 10.1371/journal.pntd.0004833. eCollection 2016 Jul.

16.

Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance.

Clapham HE, Quyen TH, Kien DT, Dorigatti I, Simmons CP, Ferguson NM.

PLoS Comput Biol. 2016 May 23;12(5):e1004951. doi: 10.1371/journal.pcbi.1004951. eCollection 2016 May.

17.

Ebola Virus Disease among Male and Female Persons in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Nedjati-Gilani G, Newton E, Nouvellet P, Perkins D, Riley S, Schumacher D, Shah A, Thomas LJ, Van Kerkhove MD.

N Engl J Med. 2016 Jan 7;374(1):96-8. doi: 10.1056/NEJMc1510305. No abstract available.

18.

The role of rapid diagnostics in managing Ebola epidemics.

Nouvellet P, Garske T, Mills HL, Nedjati-Gilani G, Hinsley W, Blake IM, Van Kerkhove MD, Cori A, Dorigatti I, Jombart T, Riley S, Fraser C, Donnelly CA, Ferguson NM.

Nature. 2015 Dec 3;528(7580):S109-16. doi: 10.1038/nature16041.

19.

Potential Biases in Estimating Absolute and Relative Case-Fatality Risks during Outbreaks.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, Ferguson NM, Garske T, Mills HL, Riley S, Van Kerkhove MD, Hernán MA.

PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003846. doi: 10.1371/journal.pntd.0003846. eCollection 2015. Review.

20.

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Dorigatti I, Aguas R, Donnelly CA, Guy B, Coudeville L, Jackson N, Saville M, Ferguson NM.

Vaccine. 2015 Jul 17;33(31):3746-51. doi: 10.1016/j.vaccine.2015.05.059. Epub 2015 Jun 4.

21.

Estimating dengue transmission intensity from sero-prevalence surveys in multiple countries.

Imai N, Dorigatti I, Cauchemez S, Ferguson NM.

PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003719. doi: 10.1371/journal.pntd.0003719. eCollection 2015 Apr.

22.

Ebola virus disease among children in West Africa.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Blake IM, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Fowler RA, Fraser C, Garske T, Hinsley W, Jombart T, Mills HL, Murthy S, Nedjati Gilani G, Nouvellet P, Pelletier L, Riley S, Schumacher D, Shah A, Van Kerkhove MD.

N Engl J Med. 2015 Mar 26;372(13):1274-7. doi: 10.1056/NEJMc1415318. No abstract available.

23.

West African Ebola epidemic after one year--slowing but not yet under control.

WHO Ebola Response Team, Agua-Agum J, Ariyarajah A, Aylward B, Blake IM, Brennan R, Cori A, Donnelly CA, Dorigatti I, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fraser C, Garcia E, Garske T, Hinsley W, Holmes D, Hugonnet S, Iyengar S, Jombart T, Krishnan R, Meijers S, Mills HL, Mohamed Y, Nedjati-Gilani G, Newton E, Nouvellet P, Pelletier L, Perkins D, Riley S, Sagrado M, Schnitzler J, Schumacher D, Shah A, Van Kerkhove MD, Varsaneux O, Wijekoon Kannangarage N.

N Engl J Med. 2015 Feb 5;372(6):584-7. doi: 10.1056/NEJMc1414992. Epub 2014 Dec 24. No abstract available.

24.

Increased transmissibility explains the third wave of infection by the 2009 H1N1 pandemic virus in England.

Dorigatti I, Cauchemez S, Ferguson NM.

Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13422-7. doi: 10.1073/pnas.1303117110. Epub 2013 Jul 23.

25.

A new approach to characterising infectious disease transmission dynamics from sentinel surveillance: application to the Italian 2009-2010 A/H1N1 influenza pandemic.

Dorigatti I, Cauchemez S, Pugliese A, Ferguson NM.

Epidemics. 2012 Mar;4(1):9-21. doi: 10.1016/j.epidem.2011.11.001. Epub 2011 Nov 28.

26.

Analysis of a vaccine model with cross-immunity: when can two competing infectious strains coexist?

Dorigatti I, Pugliese A.

Math Biosci. 2011 Nov;234(1):33-46. doi: 10.1016/j.mbs.2011.08.004. Epub 2011 Aug 18.

PMID:
21871463
27.

Modelling the spatial spread of H7N1 avian influenza virus among poultry farms in Italy.

Dorigatti I, Mulatti P, Rosà R, Pugliese A, Busani L.

Epidemics. 2010 Mar;2(1):29-35. doi: 10.1016/j.epidem.2010.01.002. Epub 2010 Feb 10.

PMID:
21352774
28.

Networks in plant epidemiology: from genes to landscapes, countries, and continents.

Moslonka-Lefebvre M, Finley A, Dorigatti I, Dehnen-Schmutz K, Harwood T, Jeger MJ, Xu X, Holdenrieder O, Pautasso M.

Phytopathology. 2011 Apr;101(4):392-403. doi: 10.1094/PHYTO-07-10-0192. Review.

Supplemental Content

Loading ...
Support Center